<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>58</viewCount><searchCount>0</searchCount></scores><additional><submitter>Ding K</submitter><funding>Henan University of Science and Technology</funding><funding>National Natural Science Foundation of China</funding><funding>Science and Technology Research Program of Henan Province</funding><pagination>232-241</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5879071</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(2)</volume><pubmed_abstract>Newcastle disease virus (NDV) and &lt;i>Salmonella&lt;/i> Pullorum have significant damaging effects on the poultry industry, but no previous vaccine can protect poultry effectively. In this study, a recombinant-attenuated &lt;i>S.&lt;/i> Pullorum strain secreting the NDV hemagglutinin-neuraminidase (HN) protein, C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA-HN), was constructed by using the suicide plasmid pRE&lt;i>asd&lt;/i>-mediated bacteria homologous recombination method to form a new bivalent vaccine candidate against Newcastle disease (ND) and &lt;i>S&lt;/i>. Pullorum disease (PD). The effect of this vaccine candidate was compared with those of the NDV LaSota and C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA) strains. The serum hemagglutination inhibition antibody titers, serum immunoglobulin G (IgG) antibodies, secretory IgA, and stimulation index in lymphocyte proliferation were increased significantly more (&lt;i>p&lt;/i> &lt; 0.01) in chickens inoculated with C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA-HN) than with C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA) but were not significantly increased compared with the chickens immunized with the LaSota live vaccine (&lt;i>p&lt;/i> > 0.05). Moreover, the novel strain provides 60% and 80% protective efficacy against the NDV virulent strain F48E9 and the &lt;i>S&lt;/i>. Pullorum virulent strain C79-13. In summary, in this study, a recombinant-attenuated &lt;i>S&lt;/i>. Pullorum strain secreting NDV HN protein was constructed. The generation of the &lt;i>S&lt;/i>. Pullorum C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA-HN) strain provides a foundation for the development of an effective living-vector double vaccine against ND and PD.</pubmed_abstract><journal>Journal of veterinary science</journal><pubmed_title>Recombinant-attenuated &lt;i>Salmonella&lt;/i> Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and &lt;i>Salmonella&lt;/i> Pullorum challenge.</pubmed_title><pmcid>PMC5879071</pmcid><funding_grant_id>152102110078</funding_grant_id><funding_grant_id>13480068</funding_grant_id><funding_grant_id>2015SPT004</funding_grant_id><funding_grant_id>31572489</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Jia YY</pubmed_authors><pubmed_authors>Yu C</pubmed_authors><pubmed_authors>Liao CS</pubmed_authors><pubmed_authors>Shang K</pubmed_authors><pubmed_authors>Yu ZH</pubmed_authors><pubmed_authors>He L</pubmed_authors><pubmed_authors>Li YJ</pubmed_authors><pubmed_authors>Ding K</pubmed_authors><pubmed_authors>Zhang CJ</pubmed_authors><pubmed_authors>Wu TC</pubmed_authors><pubmed_authors>Cheng XC</pubmed_authors><view_count>58</view_count></additional><is_claimable>false</is_claimable><name>Recombinant-attenuated &lt;i>Salmonella&lt;/i> Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and &lt;i>Salmonella&lt;/i> Pullorum challenge.</name><description>Newcastle disease virus (NDV) and &lt;i>Salmonella&lt;/i> Pullorum have significant damaging effects on the poultry industry, but no previous vaccine can protect poultry effectively. In this study, a recombinant-attenuated &lt;i>S.&lt;/i> Pullorum strain secreting the NDV hemagglutinin-neuraminidase (HN) protein, C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA-HN), was constructed by using the suicide plasmid pRE&lt;i>asd&lt;/i>-mediated bacteria homologous recombination method to form a new bivalent vaccine candidate against Newcastle disease (ND) and &lt;i>S&lt;/i>. Pullorum disease (PD). The effect of this vaccine candidate was compared with those of the NDV LaSota and C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA) strains. The serum hemagglutination inhibition antibody titers, serum immunoglobulin G (IgG) antibodies, secretory IgA, and stimulation index in lymphocyte proliferation were increased significantly more (&lt;i>p&lt;/i> &lt; 0.01) in chickens inoculated with C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA-HN) than with C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA) but were not significantly increased compared with the chickens immunized with the LaSota live vaccine (&lt;i>p&lt;/i> > 0.05). Moreover, the novel strain provides 60% and 80% protective efficacy against the NDV virulent strain F48E9 and the &lt;i>S&lt;/i>. Pullorum virulent strain C79-13. In summary, in this study, a recombinant-attenuated &lt;i>S&lt;/i>. Pullorum strain secreting NDV HN protein was constructed. The generation of the &lt;i>S&lt;/i>. Pullorum C79-13Δ&lt;i>crp&lt;/i>Δ&lt;i>asd&lt;/i> (pYA-HN) strain provides a foundation for the development of an effective living-vector double vaccine against ND and PD.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Mar</publication><modification>2024-11-20T23:43:14.116Z</modification><creation>2019-03-26T23:26:01Z</creation></dates><accession>S-EPMC5879071</accession><cross_references><pubmed>29032660</pubmed><doi>10.4142/jvs.2018.19.2.232</doi></cross_references></HashMap>